UK markets closed

Vaccitech plc (VACC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.6800+0.2200 (+4.93%)
At close: 03:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close4.4600
Open4.6400
Bid4.6000 x 1100
Ask5.4200 x 800
Day's range4.3108 - 4.6800
52-week range2.9700 - 16.5000
Volume13,437
Avg. volume7,391
Market cap174.172M
Beta (5Y monthly)N/A
PE ratio (TTM)11.41
EPS (TTM)0.4100
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est19.50
  • Simply Wall St.

    Vaccitech plc Beat Analyst Profit Forecasts, And Analysts Have New Estimates

    Last week, you might have seen that Vaccitech plc ( NASDAQ:VACC ) released its second-quarter result to the market. The...

  • Globe Newswire

    Vaccitech Reports Second Quarter 2022 Financial Results and Recent Corporate Developments

    OXFORD, United Kingdom, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC) today announced its financial results for the second quarter ended June 30, 2022 and provided an overview of the Company’s recent corporate developments. Vaccitech is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases, autoimmunity, and cancer. “The highlight of another productive q

  • Globe Newswire

    Vaccitech to Present at the William Blair Biotech Focus Conference 2022

    OXFORD, United Kingdom, July 07, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines, today announced that the Company’s Chief Executive Officer, Bill Enright, will participate in a fireside chat at the William Blair Biotech Focus Conference 2022 in New York, July 11 to 12. Mr. Enright will also host one on one meetings with investors at the conference. The webcast of t